Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » UNITE4TB CAG attends first face-to-face project meeting
The UNITE4TB project is a new, 7-year long, public-private partnership that aims to improve the care and treatment of tuberculosis (TB). TB is currently one of the top 10 causes of death worldwide. The project aims to speed up the development of new drug regimes (which medications you take and when) to treat the condition.
ELF has formed a Community Advisory Group (CAG), to ensure that the views of the TB community are heard and considered throughout the project. The group comprises members from across the world with expertise and experience of working with TB communities.
On 10-12 May 2022 the project held its first face-to-face annual meeting in Munich, Germany. Four members of the CAG attended and two gave a presentation to introduce the group and explain how they will contribute to the project. They also spoke of the importance of using appropriate language when referring to people with TB, for example not using words such as ‘sufferer’ and ‘patient’, to break down some of the stigma associated with the disease. The presentation was well-received by the other project members. Several arranged for the CAG to provide input into their part of the project.
CAG member Blessi Kumar, CEO of The Global Coalition of TB Advocates, also took part in a panel discussion titled ‘From clinical trials to access’. She emphasised the need to work collaboratively with TB communities to ensure the project reaches those who will benefit the most. Blessi commented: “This project gives people affected by TB hope!”
You can find out more about the UNITE4TB project: www.unite4tb.org
Read more about ELF’s role in the project: https://europeanlung.org/en/news-and-blog/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
No description